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Objective: We sought to determine whether type and location of thromboembolic
disease in the pulmonary vascular tree predicts the hemodynamic result and clinical
outcome in patients undergoing pulmonary endarterectomy.
Methods: From 1998 to 2000, 202 patients with pulmonary hypertension and
pulmonary vascular resistance ranging from 194 to 2950 dynes-s-cm5 underwent
pulmonary endarterectomy. Preoperative and postoperative tricuspid valve function,
pulmonary artery pressure, and pulmonary vascular resistance were determined by
means of transthoracic echocardiography and measurements with a Swan-Ganz
catheter (Edwards Lifesciences, Irvine, Calif), respectively. Patients underwent
intraoperative classification of thromboembolism as follows: type 1 (76 patients),
fresh thrombus in the main-lobar pulmonary arteries; type 2 (81 patients), intimal
thickening and fibrosis proximal to the segmental arteries; type 3 (38 patients),
disease within distal segmental arteries only; and type 4 (7 patients), distal arteriolar
vasculopathy without visible thromboembolic disease.
Results: Overall perioperative mortality was 4.5% (9/202 patients). By means of
univariate analysis, patients with type 3 or 4 disease (distal pulmonary vasculopa-
thy) had more residual postoperative tricuspid regurgitation (P  .0001), higher
postoperative pulmonary artery systolic pressure (P  .0001), and greater postop-
erative pulmonary vascular resistance (P  .0001) compared with that seen in
patients with type 1 or 2 disease, in whom thromboembolic disease was more
surgically accessible. Factors such as severity of preoperative tricuspid regurgita-
tion, patient age, and circulatory arrest time had no correlation with postoperative
hemodynamic improvement. Patients with distal thromboembolic disease (type 3-4)
had higher perioperative mortality, required longer inotropic support, and had longer
hospital stays compared with patients with type 1 or 2 thromboembolic disease.
Conclusion: The degree of improvement in pulmonary hypertension and tricuspid
regurgitation after pulmonary endarterectomy is determined by the type and location
of pulmonary thromboembolic disease. Classification of thromboembolism is useful
for predicting patient outcome after pulmonary endarterectomy.
Chronic thromboembolic pulmonary hypertension is a rare diseasethat is estimated to result in fewer than 1% of all cases of acutepulmonary embolism.1,2Several mechanisms have been postulatedto cause chronic pulmonary hypertension after an acute embolicevent. These include a recurrence of embolism reported after 2.5%to 7% of adequately treated pulmonary embolic events,3 in situ
thrombus propagation into branch pulmonary vessels,4 and failure to resolve the
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initial embolus, leading to large- and small-vessel vascu-
lopathy.5 In the proximal pulmonary arterial tree, unre-
solved pulmonary emboli cause vascular obstruction by
means of 2 mechanisms: (1) by direct occlusion of the
vessel lumen and (2) by inducing secondary endothelial
changes of cellular hyperplasia, webbing, and incomplete
clot remodeling.6,7 In a subset of patients with chronic
thromboembolism, the terminal pulmonary arterioles and
capillaries also manifest a pathologic process similar to that
seen in primary pulmonary hypertension, whereby these
small vessels become excessively thickened by muscular
hypertrophy and hyperplasia, leading to eventual occlu-
sion.8
A spectrum of these acute and chronic pulmonary vas-
cular changes are encountered at the time of pulmonary
endarterectomy for chronic pulmonary hypertension. Al-
though pulmonary endarterectomy is now a widely accept-
able operation for thromboembolic pulmonary hypertension
with perioperative mortality rates as low as 5.3%,9 little is
known about the anatomic factors that affect surgical out-
come. In specific, the influence of pulmonary vascular
changes, such as acute or chronic embolism, location of
thromboembolic material in the pulmonary arterial tree, and
the degree of distal small-vessel vasculopathy on the out-
come of pulmonary endarterectomy, has not been estab-
lished.
This study was designed as a prospective analysis of
patients undergoing isolated pulmonary endarterectomy at
our institution over a 2-year period to examine whether
anatomic intravascular factors, such as location, extent, and
type of clot, would predict postoperative hemodynamic
function, resolution of tricuspid regurgitation (TR), and
improvement in pulmonary vascular resistance. A classifi-
cation scheme for thromboembolism has previously been
reported.7 We validate that this classification system allows
for the prediction of early patient outcome after pulmonary
endarterectomy.
Methods
Patient Selection
We identified and followed 202 patients with complete medical
records (101 men and 101 women; mean age, 54.7 years; range,
18-76 years) from the University of California, San Diego, Pul-
monary Endarterectomy Registry, who underwent surgical inter-
vention between July 1998 and December 2000. This prospec-
tively collected and validated database provides comprehensive
descriptions of clinical and surgical characteristics of most patients
undergoing pulmonary endarterectomy at our institution since
1996. During the time period of this study, 290 patients underwent
pulmonary endarterectomy alone or in conjunction with foramen
ovale closure, and 27 patients underwent pulmonary endarterec-
tomy combined with other cardiac operations. Patients undergoing
concomitant coronary revascularization or valve repair-replace-
ment at the time of pulmonary endarterectomy were excluded from
this study. The selection criteria for patients undergoing pulmo-
nary endarterectomy included (1) New York Heart Association
(NYHA) class III or IV, (2) pulmonary vascular resistance of
greater than 200 dynes-s-cm5, (3) absence of significant noncar-
diac comorbid disease, and (4) appearance of chronic thrombi on
pulmonary angiogram. Preoperative inotropic support included
dopamine, epinephrine, or both in 5 patients and intra-aortic bal-
loon counterpulsation in 1 patient. Three patients were ventilator
dependent before the operation. Oral medications at the time of the
operation included loop diuretics (198/202 [98.0%] patients), me-
tolazone (45/202 [22.3%] patients), digoxin (37/202 [18.3%] pa-
tients), angiotensin-converting enzyme inhibitor (107/202 [53.0%]
patients), -blocker (15/202 [7.4%] patients), and warfarin (98/202
[48.5%] patients). All patients underwent preoperative insertion of
an inferior vena caval Greenfield filter.
Surgical Classification and Hemodynamic
Measurement
Our surgical method of pulmonary endarterectomy has been pre-
viously described.10 Two surgeons performed all operations on
cardiopulmonary bypass with a period of circulatory arrest ranging
from 12 to 73 minutes (mean, 31.0 minutes) for the distal-most
portion of the endarterectomy procedure for both lungs. In this
study we wished to validate, in a prospective fashion, whether
thrombus type and location described in our classification system
was a predictor of early postoperative outcome. To this end, during
the operation, thromboembolic disease was visualized and classi-
fied into one of 4 groups: type 1 (76 patients), fresh (acute)
thrombus in the main-lobar pulmonary arteries; type 2 (81 pa-
tients), intimal thickening and fibrosis with or without organized
thrombus proximal to segmental arteries; type 3 (38 patients),
fibrosis, intimal webbing, and thickening with or without orga-
nized thrombus within distal segmental arteries only; and type 4 (7
patients), microscopic distal arteriolar vasculopathy without visi-
ble thromboembolic disease (Figure 1). At the time of surgery,
photographs of each endarterectomy specimen were taken and
incorporated into the patient’s medical record and into the Uni-
versity of California, San Diego, Pulmonary Endarterectomy Da-
tabase for blinded review. Forty-one patients manifested different
disease types in the right and left pulmonary vasculature. For these
patients, the thromboembolism classification was noted for each
side. When there was discrepancy between disease type between
the right and left sides, the more proximal thromboembolism
classification was used for statistical analysis in this study. Eighty
patients (31 with type 1 disease, 30 with type 2 disease, 16 with
type 3 disease, and 3 with type 4 disease) underwent simultaneous
closure of a secondary foramen ovale opened by means of in-
creased right atrial pressures.
Severity of TR was graded by transthoracic echocardiography
as mild to severe (1-4) on the basis of a composite analysis of
measurements of jet area, ratio of TR jet area to right atrial area,
and pulsed-wave Doppler interrogation of the hepatic veins.11 A
TR jet area that was limited to the immediate atrial aspect of the
tricuspid valve and filled less than 33% of the right atrium (RA)
was defined as 1. A jet filling 33% to 66% of the RA was defined
as 2, whereas a 3 TR jet area was defined as filling more than
66% of the RA. A 4 TR jet both filled greater than 66% of the
RA and caused systolic flow reversal in the hepatic veins. Maximal
regurgitant jet areas were chosen for all measurements. Continu-
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ous-wave Doppler interrogation of TR jet velocity was performed
in parasternal, apical, and subcostal imaging positions. The max-
imal velocity obtained was identified as peak TR velocity and was
used to calculate the peak gradient between the right ventricle and
the RA through the modified Bernouilli equation.12 Two-dimen-
sional and Doppler echocardiography was performed by an echo-
cardiographer with specific expertise in pulmonary hypertension
using a Hewlett-Packard (Andover, Mass) Sonos 5500 echocar-
diography unit with broadband 2-dimensional Doppler trans-
ducers. Confirmatory blind Doppler assessment of peak TR
velocity with a Pedoff continuous-wave probe was also per-
formed in all patients.
Tricuspid valve morphology was evaluated both preoperatively
and postoperatively in the apical 4-chamber, subcostal, parasternal
short-axis view and modified parasternal long-axis (right atrial/
right ventricular) views to differentiate functional from organic
TR. Functional TR (which accounted for all cases of TR in the
study group) was defined as a lack of leaflet coaptation or failure
of the valve leaflets to reach the plane of the tricuspid anulus
during systole without evidence of structural abnormalities. Or-
ganic TR, defined as the presence of valvular doming or thicken-
ing, flail valvular chordae, or ruptured papillary muscle, was not
seen in any patient in this study.
Preoperative hemodynamics were assessed 3.3 months to 1 day
before the operation by means of right heart catheterization (195
patients on an elective outpatient basis and 7 patients on an urgent
inpatient basis). Left heart catheterization with coronary angiog-
raphy was performed for all patients greater than 55 years of age.
Postoperative hemodynamic measurements were made, with each
patient weaned from inotropic and vasodilator support before
Swan-Ganz line (Edwards Lifesciences, Irvine, Calif) removal 1 to
14 days (mean, 2.1 days) after the operation. Screening postoper-
ative transthoracic echocardiography was performed 48 hours be-
fore hospital discharge (mean, 10.8 days after the operation) for
each patient.
Statistical Methods
Duration of times were summarized as medians, and other contin-
uous variables were reported as means  SD. Categoric variables
were expressed as numbers and percentages. Global comparisons
among thromboembolism classifications were performed by using
1-way analyses of variance with transformations when needed,
Figure 1. Pulmonary angiograms and corresponding specimens removed at the time of pulmonary endarterectomy:
type 1 disease, fresh thrombus in main-lobar arteries (note abrupt cutoff of branches and lack of filling to the
periphery on angiography; type 2 disease, organized thrombus and intimal thickening proximal to segmental
arteries (note poststenotic dilatation of the lower lobar vessel and lack of filling to the periphery on angiography);
type 3 disease, intimal thickening-fibrosis in distal segmental arteries, with surgical plane raised at each
segmental level; type 4 disease, distal arteriolar vasculopathy with removal of normal intimal layer and no
intraluminal disease.
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Kruskal-Wallis tests, and Fisher-Freeman-Halton exact tests. Post
hoc comparisons were performed by using the Tukey honestly
significant difference tests. Student t tests and Wilcoxon rank sum
tests were used to test the relationship of potential predictors with
outcome measures. TR, an ordinal categoric outcome measure,
was treated as a continuous variable because of its assumed re-
flection of an underlying continuous distribution. P values are
reported for all statistical tests. Data were analyzed with JMP and
SAS (Version 4.0.4 and Version 8, respectively; SAS Institute Inc,
Cary, NC) and Minitab (Release 13.3; Minitab Inc, State College,
Pa) software.
Results
All 202 patients in this study underwent bilateral pulmonary
endarterectomy. Characteristics of patients at the time of
operation for each thromboembolism classification group
are detailed in Table 1. The 4 patient groups were similar
with respect to age, preoperative pulmonary artery pres-
sures, pulmonary vascular resistance, and tricuspid regurgi-
tant velocity. There was no statistically significant differ-
ence in the mean preoperative cardiac output or percentage
of patients with NYHA functional class IV symptoms
among the 4 groups. A larger proportion of pulmonary
endarterectomy patients with type 1 or 2 disease had a
previous history of deep venous thrombosis (29.3%) or
pulmonary embolism (56.3%) than patients with more distal
pulmonary arterial disease (groups 3 and 4), who had a
22.7% history of deep venous thrombosis and 40.9% inci-
dence of preoperative pulmonary embolism.
There were significant differences between patients with
type 1 and 2 disease (proximal arterial clot-vasculopathy)
compared with patients with type 3 and 4 disease (segmen-
tal artery or distal arteriolar vasculopathy) with respect to a
decrease in tricuspid regurgitant velocity (P  .0001) and
downgrading of TR after pulmonary endarterectomy (P 
.0001, Figure 2). Overall, patients with more proximal
thromboembolic disease had a trend toward greater im-
provement in all measured components of TR, including
tricuspid valve annular diameter, leaflet coaptation, and
regurgitant jet area after the operation compared with pa-
tients with segmental artery and distal small-vessel vascu-
lopathy.
Table 2 presents the mean change between preoperative
and postoperative hemodynamic parameters of pulmonary
artery pressure, pulmonary vascular resistance, right ven-
tricular systolic pressure, and cardiac index among the 4
patient classification groups. Postoperative hemodynamic
measurements were made with the patients weaned from all
inotropic and vasodilator support just before Swan-Ganz
line removal. There was significant difference between the
mean diminution in pulmonary artery systolic pressure and
the mean decrease in pulmonary vascular resistance be-
tween patients with proximal disease (groups 1 and 2)
compared with patients with distal disease (groups 3 and 4,
P .0001). Patients undergoing pulmonary endarterectomy
for fresh clot or intimal thickening-fibrosis in the main or
lobar pulmonary arteries (groups 1 and 2) had, in general, a
greater increase in postoperative cardiac index and decrease
in right ventricular systolic pressure compared with patients
who had disease within segmental or distal branch arteries
(groups 3 and 4), although this did not achieve statistical
significance. We also found that group 1 patients with fresh
clot in the main or lobar pulmonary arteries were similar
TABLE 1. Preoperative patient characteristics
Variable
Thromboembolism classification group
P value
1
(n  76)
2
(n  81)
3
(n  38)
4
(n  7)
Age (y) 51.0 15.1 48.3 13.3 48.3 13.4 47.1 20.5 .605
Male sex (%) 38 (50.0) 32 (39.5) 18 (47.4) 3 (42.9) .607
Pulmonary artery pressure (mm Hg)
Systolic 78.3 17.9 80.2 19.1 73.4 17.5 71.3 15.8 .216
Diastolic 32.5 9.6 31.0 9.3 32.1 11.3 33.3 11.6 .773
Pulmonary vascular resistance (dynes-s-cm5) 911.1 436.5 805.3 370.1 902.8 504.1 1015.1 481.7 .310
Cardiac index (L/min) 3.01 0.37 3.14 0.54 2.98 0.48 2.87 0.57 .150
Tricuspid regurgitant jet (M/s) 4.36 0.74 4.27 0.72 4.25 0.87 4.44 0.44 .772
PaO2 77 15.9 72 20.7 68 18.4 74 14.4 .420
FEVI 2.16 0.21 2.09 0.30 2.10 0.33 2.20 0.37 .227
Hematocrit (%) 37.7 5.2 37.8 4.6 38.1 2.8 37.6 3.5 .923
NYHA class
I 1 (1.3) 0 (0) 0 (0) 0 (0)
II 28 (36.8) 27 (33.3) 13 (34.2) 2 (28.6)
III 41 (54.0) 48 (59.3) 22 (57.9) 4 (57.1)
IV 6 (7.9) 6 (7.4) 3 (7.9) 1 (14.3)
Data are shown as mean  SD or number (percentage).
FEVI, Forced expiratory volume in 1 second.
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Figure 2. Comparison of tricuspid regurgitant jet velocity (A) and graded tricuspid reguirgitation (B) before and after
pulmonary endarterectomy. P values express comparisons between preoperative and postoperative values for
each thromboembolism classification group.
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with respect to postoperative hemodynamic outcome (mean
decrease in pulmonary artery systolic pressure, pulmonary
vascular resistance, and increase in cardiac index) compared
with group 2 patients with disease in the same anatomic
location but with organized thrombus and intimal fibrosis as
the main pathology in the main or lobar pulmonary arteries.
The intraoperative location of thromboembolic disease
was a predictor of short-term mortality and hospital length
of stay (Table 3). Patients with type 4 disease (distal arterial
vasculopathy) had the highest mortality rate of 14.3% at 1
month after the operation. Although suspected to have
thromboembolic disease on the basis of preoperative pul-
monary angiography, this small subset of patients had distal
vascular disease (ie, primary pulmonary hypertension) with-
out apparent thromboembolism. We found that operations
in these patients did little to improve pulmonary vascular
resistance or cardiac function. Most (6/7 patients) had per-
sistent postoperative pulmonary hypertension and right
heart failure, leading to prolonged inotropic dependence and
longer intensive care unit stays.
Patients with type 1 and 2 disease had significantly
higher perioperative survival (154/157 [98.1%] patients)
compared with that seen in patients with type 3 and 4
disease (39/45 [86.7%] patients, P .0045, Table 3) and an
overall lower incidence of postoperative complications (Ta-
ble 4). Atrial fibrillation, pneumonia, and reperfusion pul-
monary edema necessitating ventilator dependence for more
than 3 postoperative days were the most prevalent compli-
cations in each patient group.
Whereas before surgery most patients undergoing pul-
monary endarterectomy were in NYHA functional class III,
at 3 months’ follow-up after the operation, 87.9% (138/157)
of the individuals in groups 1 and 2 were assessed to be in
NYHA functional class I or II. These results differ from
those seen in patients with type 3 and 4 thromboembolic
disease. Most (65.7%) patients with type 3 or 4 thrombo-
embolic disease were in NYHA functional class III or IV
before surgery, with only 30.0% (9/30 patients) of these
same cohorts in NYHA functional class I or II within 3
months after the operation. Of the 7 patients with type 4
disease, only one individual experienced clinical improve-
ment after the operation, with improvement from NYHA
functional class III to II symptoms.
Discussion
Since the first reported successful operation for chronic
thromboembolic disease in the lung in 1961,13 pulmonary
endarterectomy has become an established treatment for
symptomatic and end-stage pulmonary hypertension. The
5-year survival for an adult patient diagnosed with pulmo-
nary hypertension resulting from pulmonary embolism has
been estimated to be less than 20%.14 This compares with
our institution’s 5-year survival after pulmonary endarter-
ectomy of 75%.15 From 1990 to 1999, the UNOS Scientific
Registry reported a 78% 1-month survival and 42% 5-year
survival for single- and double-lung transplantation for pul-
monary hypertension and 67% 1-month survival and 36%
5-year survival for heart-lung transplantation for pulmonary
hypertension.16 These results suggest that pulmonary end-
arterectomy is the treatment of choice for chronic pulmo-
nary thromboembolic disease.
However, despite favorable results in our series of over
1300 pulmonary endarterectomies performed over the last
10 years,17 we have come to realize that the disease process
resulting from thromboembolic occlusion of branch pulmo-
nary arteries causes a spectrum of vascular disease in the
lung. At the time of the operation, a range of distinct
pathologies reflecting absorption and remodeling of clot,
secondary neointimal changes adjacent to vessels that carry
clot, and a distal vasculopathic process remote to the throm-
boembolic disease have been encountered. We have always
been intrigued by the fact that more than 60% of the patients
we operate on with angiographic evidence of main or lobar
pulmonary arterial obstruction have no frank clot but rather
have secondary intimal thickening and webbing, partially
organized thrombus, or both as the cause of the proximal
obstruction.
In this study we sought to determine whether the pathologic
location and type of disease in the pulmonary arterial tree is a
predictor of early postoperative outcome. Our results demon-
TABLE 2. Comparison of perioperative hemodynamic parameters
Variable
Thromboembolism classification group
P value
1
(n  76)
2
(n  81)
3
(n  38)
4
(n  7)
Mean decrease in PAS (mm Hg) 35.9 16.3 36.3 18.2 18.5 19.4 0.0 15.6 .0005
Mean decrease in PVR (dynes-s-cm5) 661.9 410.5 565.7 301.2 244.1 393.6 260.9 262.2 .0005
Mean increase in CI (L/min) 0.92 0.40 0.78 0.50 0.36 0.37 0.25 0.34 .03
Mean decrease in RVS (mm Hg) 35.4 18.4 31.1 17.4 16.0 17.1 2.1 16.2 .02
Circulatory arrest time (min) 37.1 12.9 35.5 11.3 42.3 11.5 34.9 17.3 .04
Data are shown as mean  SD or number (percentage).
PAS, pulmonary artery systolic pressure; PVR, pulmonary vascular resistance; CI, Cardiac index; RVS, right ventricular systolic pressure.
General Thoracic Surgery Thistlethwaite et al
1208 The Journal of Thoracic and Cardiovascular Surgery ● December 2002
G
TS
strate several key points. First, in almost every case, thrombo-
embolic pulmonary hypertension should be considered a bilat-
eral disease. No patient in this study had unilateral
thromboembolic pathology, and in our experience of over
1500 total pulmonary endarterectomies, the incidence of uni-
lateral disease has been less than 2%. Indeed, of the 43 patients
referred to our institution with unilateral disease since 1986, 16
patients had pulmonary artery sarcoma as the cause of obstruc-
tion (unpublished data),18 whereas only 27 patients had true
unilateral thromboembolic disease. Second, patients with
thromboembolic disease proximal to the segmental arteries
have the most favorable hemodynamic result from pulmonary
endarterectomy, as measured by normalization of pulmonary
artery pressures, improvement in pulmonary vascular resis-
tance, and resolution of TR. The pathologic nature of the
proximal disease (ie, fresh clot vs organized thrombus vs
intimal thickening) did not have any effect on postoperative
outcome. This might reflect, in part, that, during the endarter-
ectomy process, all material occluding the vascular lumina, as
well as the intima and most of the media, are removed.19
Earlier studies by Chow and colleagues20 and Dittrich and
associates21 have suggested that the majority of patients who
undergo pulmonary endarterectomy have resolution of pulmo-
nary hypertension, right heart dysfunction, and TR. However,
a small subset of patients in most large pulmonary thrombo-
endarterectomy series do not show hemodynamic improve-
ment.9,10,22,23 We have found that the small subset of patients
who do not show improvement in TR and right heart function
are those with predominantly distal thromboembolic disease.
Third, although endarterectomy can be achieved in the seg-
mental pulmonary arteries by means of direct visualization
under circulatory arrest, patients with disease limited to this
anatomic area have a worse postoperative outcome compared
with patients with more proximally located disease. Fourth, a
small subset of patients offered pulmonary endarterectomy do
not have surgically correctable disease in that the endarterec-
tomy specimen removed from these patients is normal to the
level of the distal segmental arteries. These patients’ lung
biopsy specimens demonstrated a diffuse, small-vessel vascu-
lopathic process of medial hypertrophy and hyperplasia similar
to that seen in primary pulmonary hypertension or longstand-
ing mitral disease.24 As surgery did not achieve normalization
of pulmonary artery pressures or pulmonary vascular resis-
tance in patients with isolated arteriolar and small-vessel dis-
ease, this group (type 4 disease) had the highest perioperative
mortality, greatest average length of hospitalization, and high-
est overall incidence of postoperative complications.
Patient age, degree of pulmonary hypertension, and cir-
culatory arrest time have each been identified as multivariable
risk factors for early morbidity and mortality in cardiac surgi-
cal patients.25-27 However, in stratifying patients according to
intraoperative thromboembolism classification, we did not find
these factors to be associated with hemodynamic improvement
or perioperative survival. For all patients in this 3-year cohort,
failure to lower pulmonary artery pressure at the time of the
operation was most predictive of in-hospital mortality. For all
TABLE 3. Postoperative outcome
Thromboembolism
classification group Patients
Median days
intubated
Median days on
inotropic support
Median
ICU days
Median
hospital days
One-mo
survival (%)
1 76 1 1 2 10 98.7
2 81 1 1 3 10 97.5
3 38 1 5 6 13 86.8
4 7 1 6 6 15 85.7
TABLE 4. Perioperative mortality
Complication
Thromboembolism classification group
1
(n  76),
no. of patients
(%)*
2
(n  81)
no. of patients
(%)*
3
(n  38)
no. of patients
(%)*
4
(n  7)
no. of patients
(%)*
Reperfusion edema 15 (19.7) 17 (21.0) 6 (15.8) 1 (14.2)
Atrial fibrillation 6 (7.9) 6 (7.4) 15 (39.5) 4 (57.1)
Pneumonia 1 (1.3) 3 (3.7) 7 (18.4) 2 (28.6)
Delirium 2 (2.6) 2 (2.5) 3 (7.9) 2 (28.6)
Pneumothorax 1 (1.3) 1 (1.2) 0 (0) 1 (14.3)
Pancreatitis 0 (0) 0 (0) 2 (5.3) 1 (14.3)
Clostridium difficile colitis/gastrointestinal bleeding 0 (0) 0 (0) 2 (5.3) 2 (28.6)
*Some patients counted in more than one category.
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classification groups, pneumonia and gastrointestinal compli-
cations were the postoperative complications most associated
with perioperative death.
Several limitations of this study deserve mention. This
analysis is based on an intraoperative assessment of the type
and location of thromboembolic disease on the basis of direct
observation by the surgeon and by photographic assessment of
the pulmonary vascular specimen removed at the time of the
operation. We did not perform full-thickness biopsies of dif-
ferent levels of pulmonary vasculature during the endarterec-
tomy procedure because of the inherent risk to the patients in
this study. We also did not routinely perform lung biopsy to
look for the presence of distal vasculopathic changes, except in
those patients with type 4 disease, in whom minimal endarter-
ectomy specimens were recovered. It is our impression from
other studies that longstanding proximal pulmonary arterial
obstruction might eventually induce small-vessel hypertrophy
and hyperplasia through modulation of local mediators, such as
angiopoietin 1 and bone morphogenetic protein receptors 1 and
2 (unpublished data).28 The influence of arteriolar and capillary
pulmonary hypertensive changes in the setting of visible mac-
roscopic thromboembolic disease deserves further study. In
addition, approximately one fifth of patients in this study had
different types of thromboembolic disease in the right and left
lungs. We did not believe that averaging the thromboembolic
group (ie, a patient with type 2 disease in the right lung and
type 3 disease in the left lung should be considered type 2.5)
was a valid way to pool and interpret results. Instead, we
considered patients with bilateral disease of 2 different types to
be more like the more proximal thromboembolism classifica-
tion.
In summary, this study demonstrates that intraoperative
thromboembolism classification predicts early surgical out-
come after pulmonary endarterectomy. We appreciate that
cardiac remodeling after pulmonary endarterectomy is not
complete in the perioperative period and that our reported
results reflect early hemodynamic outcome and survival
only. This cohort of patients will be followed over time to
determine whether thromboembolism classification will
also influence long-term survival and cardiac function.
Careful assessment of pulmonary vascular pathology at both
gross surgical and microscopic levels should yield further
clues as to the biology of pulmonary hypertension and the
management of this complex group of patients.
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